Compare Neurocrine Biosciences Inc (NBIX) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Victoria's Secret & Co — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Victoria's Secret & Co trades at $87.75 (market cap $6.95B). The key difference: Neurocrine Biosciences Inc is far larger — about 2.5× Victoria's Secret & Co's market cap. Which is the better fit depends on your goals.
| NBIX | VSXY | |
|---|---|---|
Market Cap | $17.40B | $6.95B |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $88.50 |
52-Week Low | $123.10 | $18.72 |
Enterprise Value | $16.49B | $9.59B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
